| Primary |
| Immunodeficiency Common Variable |
12.5% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
10.1% |
| Hypogammaglobulinaemia |
9.7% |
| Idiopathic Thrombocytopenic Purpura |
8.5% |
| Secondary Immunodeficiency |
7.3% |
| Guillain-barre Syndrome |
6.6% |
| Chronic Lymphocytic Leukaemia |
6.1% |
| Kawasaki's Disease |
5.9% |
| Myasthenia Gravis |
5.0% |
| Immunodeficiency |
4.5% |
| Premedication |
3.5% |
| Thrombocytopenia |
3.5% |
| Polyneuropathy |
2.8% |
| Dermatomyositis |
2.4% |
| Immune Thrombocytopenic Purpura |
2.4% |
| Transplant Rejection |
2.1% |
| Humoral Immune Defect |
1.9% |
| Optic Neuritis |
1.9% |
| Demyelinating Polyneuropathy |
1.7% |
| Multifocal Motor Neuropathy |
1.7% |
|
| Off Label Use |
14.9% |
| Vomiting |
13.4% |
| Haemolysis |
9.0% |
| Haemolytic Anaemia |
6.7% |
| Tachycardia |
6.3% |
| Pyrexia |
5.6% |
| Death |
5.2% |
| Meningitis Aseptic |
4.1% |
| Headache |
3.7% |
| Chills |
3.0% |
| Infusion Related Reaction |
3.0% |
| Nausea |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure |
3.0% |
| Sepsis |
3.0% |
| Urinary Tract Infection |
3.0% |
| Haemoglobin Decreased |
2.6% |
| Rash |
2.6% |
| Urticaria |
2.6% |
| Anaemia |
2.2% |
|
| Secondary |
| Hypogammaglobulinaemia |
21.7% |
| Premedication |
10.3% |
| Lung Transplant |
8.8% |
| Immunodeficiency Common Variable |
5.8% |
| Product Used For Unknown Indication |
5.8% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
4.8% |
| Myasthenia Gravis |
4.6% |
| Secondary Immunodeficiency |
4.3% |
| Systemic Lupus Erythematosus |
4.0% |
| Optic Neuritis |
3.6% |
| Idiopathic Thrombocytopenic Purpura |
3.5% |
| Muscular Weakness |
3.1% |
| Chronic Lymphocytic Leukaemia |
3.0% |
| Guillain-barre Syndrome |
3.0% |
| Immunodeficiency |
2.8% |
| Humoral Immune Defect |
2.5% |
| Dermatomyositis |
2.3% |
| Migraine |
2.3% |
| Demyelinating Polyneuropathy |
2.0% |
| Primary Immunodeficiency Syndrome |
1.8% |
|
| Off Label Use |
12.1% |
| Haemolytic Anaemia |
10.8% |
| Haemolysis |
8.8% |
| Renal Failure Chronic |
8.3% |
| Anaemia |
6.3% |
| Anti-erythrocyte Antibody Positive |
6.3% |
| Vomiting |
6.3% |
| Hepatomegaly |
5.4% |
| Clostridium Difficile Colitis |
5.0% |
| Chills |
3.8% |
| Pyrexia |
3.8% |
| Upper Respiratory Tract Infection |
3.8% |
| Superinfection Bacterial |
2.9% |
| Hypofibrinogenaemia |
2.5% |
| Influenza Like Illness |
2.5% |
| Jaundice |
2.5% |
| Sepsis |
2.5% |
| Thrombocytopenia |
2.5% |
| Antibody Test Positive |
2.1% |
| Gait Disturbance |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.5% |
| Nausea |
9.4% |
| Prophylaxis |
6.3% |
| Hypertension |
5.7% |
| Autoimmune Thrombocytopenia |
5.2% |
| Infection Prophylaxis |
4.2% |
| Immunodeficiency Common Variable |
3.6% |
| Pain |
3.6% |
| Disseminated Tuberculosis |
3.1% |
| Epilepsy |
3.1% |
| Premedication |
3.1% |
| Anxiety |
2.1% |
| Combined Immunodeficiency |
2.1% |
| Plasma Cell Myeloma |
2.1% |
| Multiple Sclerosis |
1.6% |
| Pain Management |
1.6% |
| Prophylaxis Against Graft Versus Host Disease |
1.6% |
| Antifungal Prophylaxis |
1.0% |
| Headache |
1.0% |
| Heart Transplant |
1.0% |
|
| Vomiting |
12.5% |
| Pulmonary Embolism |
8.3% |
| Wound Dehiscence |
8.3% |
| Acute Disseminated Encephalomyelitis |
4.2% |
| Convulsion |
4.2% |
| Diffuse Large B-cell Lymphoma Recurrent |
4.2% |
| Eczema |
4.2% |
| Guillain-barre Syndrome |
4.2% |
| Headache |
4.2% |
| Hypokalaemia |
4.2% |
| Hyponatraemia |
4.2% |
| Injury |
4.2% |
| Lethargy |
4.2% |
| Loss Of Consciousness |
4.2% |
| Mental Status Changes |
4.2% |
| Nausea |
4.2% |
| Overdose |
4.2% |
| Pain |
4.2% |
| Pregnancy |
4.2% |
| Pruritus |
4.2% |
|
